7LAPUSAN S, VIDRIALES MB, THOMAS X, et al. Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate,in adult pa- tients with relapsed/refractory acute myeloid leukemia [J]. Invest New Drug, 2012, 30(3): 1121-1131.
8VENGHATERI JB, GUPTA TK, VERMA PJ, et al. Ansamitocin P-3 Depolymerizes Microtubules and Induces Apoptosis by Binding to Tubulin at the Vinblastine Site[J]. Plos one, 2013,8(10): e75182.
9GERBER HP, KOEHN FE, ABRAHAM RT. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics [J]. Nat Prod Rep, 2013, 30(5): 625-639.
10SIEVERS EL, SENTER PD. Antibody-drug conjugates in cancer therapy [J]. Annu Rev Med, 2013, 64:15-29.